Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | BLU-924 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on BLU-924 (SAR449336), a putative pan-KRAS inhibitor (Jun 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| BLU-924 | BLU924|BLU 924|SAR449336|SAR 449336|SAR-449336 | KRAS Inhibitor 33 | Limited information is currently available on BLU-924 (SAR449336), a putative pan-KRAS inhibitor (Jun 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07629960 | Phase Ib/II | BLU-924 | A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations | Recruiting | USA | 0 |